380 related articles for article (PubMed ID: 30315806)
1. HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation.
Song R; Yang Y; Lei H; Wang G; Huang Y; Xue W; Wang Y; Yao L; Zhu Y
J Mol Cell Cardiol; 2018 Nov; 124():58-69. PubMed ID: 30315806
[TBL] [Abstract][Full Text] [Related]
2. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.
Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P
J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952
[TBL] [Abstract][Full Text] [Related]
3. Decreased α-tubulin acetylation induced by an acidic environment impairs autophagosome formation and leads to rat cardiomyocyte injury.
Yang L; Zhao L; Cui L; Huang Y; Ye J; Zhang Q; Jiang X; Zhang D; Huang Y
J Mol Cell Cardiol; 2019 Feb; 127():143-153. PubMed ID: 30582931
[TBL] [Abstract][Full Text] [Related]
4. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness.
Leyk J; Daly C; Janssen-Bienhold U; Kennedy BN; Richter-Landsberg C
Cell Death Dis; 2017 Aug; 8(8):e3028. PubMed ID: 29048427
[TBL] [Abstract][Full Text] [Related]
5. Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy.
McLendon PM; Ferguson BS; Osinska H; Bhuiyan MS; James J; McKinsey TA; Robbins J
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5178-86. PubMed ID: 25404307
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P
Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804
[TBL] [Abstract][Full Text] [Related]
7. Activation of histone deacetylase-6 induces contractile dysfunction through derailment of α-tubulin proteostasis in experimental and human atrial fibrillation.
Zhang D; Wu CT; Qi X; Meijering RA; Hoogstra-Berends F; Tadevosyan A; Cubukcuoglu Deniz G; Durdu S; Akar AR; Sibon OC; Nattel S; Henning RH; Brundel BJ
Circulation; 2014 Jan; 129(3):346-58. PubMed ID: 24146251
[TBL] [Abstract][Full Text] [Related]
8. Acetylation/deacetylation and microtubule associated proteins influence flagellar axonemal stability and sperm motility.
Chawan V; Yevate S; Gajbhiye R; Kulkarni V; Parte P
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33200789
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase 6 inhibition restores autophagic flux to promote functional recovery after spinal cord injury.
Zheng Z; Zhou Y; Ye L; Lu Q; Zhang K; Zhang J; Xie L; Wu Y; Xu K; Zhang H; Xiao J
Exp Neurol; 2020 Feb; 324():113138. PubMed ID: 31794745
[TBL] [Abstract][Full Text] [Related]
10. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
Yu J; Ma Z; Shetty S; Ma M; Fu J
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
[TBL] [Abstract][Full Text] [Related]
11. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
Gold WA; Lacina TA; Cantrill LC; Christodoulou J
J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
Wattanathamsan O; Chantaravisoot N; Wongkongkathep P; Kungsukool S; Chetprayoon P; Chanvorachote P; Vinayanuwattikun C; Pongrakhananon V
J Biomed Sci; 2023 Jan; 30(1):4. PubMed ID: 36639650
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth.
Van Helleputte L; Kater M; Cook DP; Eykens C; Rossaert E; Haeck W; Jaspers T; Geens N; Vanden Berghe P; Gysemans C; Mathieu C; Robberecht W; Van Damme P; Cavaletti G; Jarpe M; Van Den Bosch L
Neurobiol Dis; 2018 Mar; 111():59-69. PubMed ID: 29197621
[TBL] [Abstract][Full Text] [Related]
14. HDAC6 inhibition blocks inflammatory signaling and caspase-1 activation in LPS-induced acute lung injury.
Liu L; Zhou X; Shetty S; Hou G; Wang Q; Fu J
Toxicol Appl Pharmacol; 2019 May; 370():178-183. PubMed ID: 30910594
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells.
Asthana J; Kapoor S; Mohan R; Panda D
J Biol Chem; 2013 Aug; 288(31):22516-26. PubMed ID: 23798680
[TBL] [Abstract][Full Text] [Related]
16. HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice.
Picci C; Wong VSC; Costa CJ; McKinnon MC; Goldberg DC; Swift M; Alam NM; Prusky GT; Shen S; Kozikowski AP; Willis DE; Langley B
Exp Neurol; 2020 Jun; 328():113281. PubMed ID: 32147437
[TBL] [Abstract][Full Text] [Related]
17. Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models.
Depetter Y; Geurs S; De Vreese R; Goethals S; Vandoorn E; Laevens A; Steenbrugge J; Meyer E; de Tullio P; Bracke M; D'hooghe M; De Wever O
Int J Cancer; 2019 Aug; 145(3):735-747. PubMed ID: 30694564
[TBL] [Abstract][Full Text] [Related]
18. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HDAC6 by tubastatin A disrupts mouse oocyte meiosis via regulating histone modifications and mRNA expression.
Sui L; Huang R; Yu H; Zhang S; Li Z
J Cell Physiol; 2020 Oct; 235(10):7030-7042. PubMed ID: 32017059
[TBL] [Abstract][Full Text] [Related]
20. HDAC6-mediated α-tubulin deacetylation suppresses autophagy and enhances motility of podocytes in diabetic nephropathy.
Liang T; Qi C; Lai Y; Xie J; Wang H; Zhang L; Lin T; Jv M; Li J; Wang Y; Zhang Y; Chen Z; Qiu X; Li R; Li Z; Ye Z; Liu S; Liang X; Shi W; Wang W
J Cell Mol Med; 2020 Oct; 24(19):11558-11572. PubMed ID: 32885602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]